Literature DB >> 3156596

Occurrence of atrial natriuretic polypeptide in brain.

N Morii, K Nakao, A Sugawara, M Sakamoto, M Suda, M Shimokura, Y Kiso, M Kihara, Y Yamori, H Imura.   

Abstract

In order to determine whether or not atrial natriuretic polypeptides (ANPs) exist in the brain, we have studied extracts from the rat brain using a specific radioimmunoassay (RIA) for alpha-atrial natriuretic polypeptide. The presence and widespread distribution of alpha-rat ANP-like immunoreactivity (alpha-rANP-LI) have been demonstrated in the rat brain. The highest concentration of alpha-rANP-LI (20-22 ng/g) is in the hypothalamus and the septum. Moderate concentrations of alpha-rANP-LI (2-8 ng/g) are also found in the midbrain, cerebral cortex, olfactory bulb, thalamus, pons-medulla and hippocampus. High performance gel permeation chromatography coupled with the RIA revealed that alpha-rANP-LI found in the rat brain consists of three components eluting at the positions of gamma-rat ANP (gamma-rANP), beta-rat ANP (beta-rANP) and alpha-rANP, respectively. Among these a low molecular weight form of alpha-rANP-LI emerging at the elution position corresponding to alpha-rANP is predominant in the rat brain. This is in contrast to the finding that gamma-rANP, a high molecular weight form of 13k daltons is the dominant form of alpha-rANP-LI in the rat atrium. These results clearly show that there exists a widespread neural system containing ANPs in the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156596     DOI: 10.1016/s0006-291x(85)80176-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

2.  Immunohistochemistry of atrial natriuretic peptide in brain infarction.

Authors:  M Nogami; J Shiga; A Takatsu; N Endo; I Ishiyama
Journal:  Histochem J       Date:  2001-02

3.  Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; M Apostolakis; S Bountzioukas; O Guiba-Tziampiri; H Kontoleon-Vakalopoulou; K Mavroudis
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

4.  Visualisation of specific binding sites for atrial natriuretic peptide on non-neuronal cells of cultured rat sympathetic ganglia.

Authors:  S James; C J Hassall; J M Polak; G Burnstock
Journal:  Cell Tissue Res       Date:  1990-01       Impact factor: 5.249

5.  Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier.

Authors:  Shingo Ito; Sumio Ohtsuki; Yuki Katsukura; Miho Funaki; Yusuke Koitabashi; Akihiko Sugino; Sho Murata; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

6.  Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.

Authors:  A Sugawara; K Nakao; N Morii; T Yamada; H Itoh; S Shiono; Y Saito; M Mukoyama; H Arai; K Nishimura
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

Review 7.  The biochemistry and molecular biology of atrial natriuretic factor.

Authors:  T G Flynn; P L Davies
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

8.  Immuohistochemical demonstration of alpha-atrial natriretic plypeptide-containing neurons in the rat brain.

Authors:  M Kawata; S Ueda; K Nakao; N Morii; Y Kiso; H Imura; Y Sano
Journal:  Histochemistry       Date:  1985

9.  Atrial natriuretic peptide (ANP) attenuates brain oedema accompanying experimental subarachnoid haemorrhage.

Authors:  T P Dóczi; F Joó; I Balás
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

10.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.